Return to CG122 Overview

Ovarian cancer: recognition and initial management [CG122]

Measuring the use of this guidance


Measure serum CA125 in primary care in women with symptoms that suggest ovarian cancer (see section 1.1.1)

What was measured: Women with appropriate symptoms receiving a CA125 test.
Data collection end: December 2012
Data collection end: December 2013
Area covered: Regional
Source: Pickerskill, M., Hunt, N., Robinson, S. et al. (2014) North West regional audit of CA125 requesting in primary care, Clinical Chemistry and Laboratory Medicine, Vol 52(11): eA205–eA379

 Return to CG122 Overview